Immunovia's CLARITI Study Results to Be Presented at DDW 2025, Highlighting Advances in Pancreatic Cancer Diagnostics#Sweden#Immunovia#Lund#pancreatic_cancer#CLARITI_study
Immunovia's CLARITI Study Results to Be Presented at DDW 2025, Highlighting Advances in Pancreatic Cancer Diagnostics
The prestigious DDW 2025 conference will feature Immunovia's CLARITI study results, underlining significant advancements in pancreatic cancer detection.
third-news.com
March 3, 2025 at 8:00 AM
Immunovia's CLARITI Study Results to Be Presented at DDW 2025, Highlighting Advances in Pancreatic Cancer Diagnostics#Sweden#Immunovia#Lund#pancreatic_cancer#CLARITI_study
Immunovia Breakthrough: Clinical Validation for Pancreatic Cancer Test Shows High Accuracy and Promising Results#Sweden#Immunovia#Lund#pancreatic_cancer#CLARITI_study
Immunovia Breakthrough: Clinical Validation for Pancreatic Cancer Test Shows High Accuracy and Promising Results
Immunovia has announced promising results from the CLARITI study, revealing high accuracy in early-stage pancreatic cancer detection, marking a significant advancement in diagnostics.
third-news.com
December 9, 2024 at 7:55 AM
Immunovia Breakthrough: Clinical Validation for Pancreatic Cancer Test Shows High Accuracy and Promising Results#Sweden#Immunovia#Lund#pancreatic_cancer#CLARITI_study